Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Randox to automate AspirinWorks:

This article was originally published in Clinica

Executive Summary

Corgenix Medical is to automate its AspirinWorks diagnostic technology in collaboration with Crumlin, Northern Ireland IVD company Randox Laboratories. The firms will work together to adapt the product to a format compatible with automated chemistry analysers, making it suitable for high volume clinical testing. The AspirinWorks test will be manufactured at Randox's facilities in the UK, and the two companies will share global distribution rights for the resulting product. Corgenix, of Denver, Colorado, expects to launch the automated test in 2009. AspirinWorks is a urine-based test for determining the effect of aspirin therapy on blood clotting.

Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT046671

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel